Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Pyridoxal-phosphate | hsa00260 | Glycine, serine and threonine metabolism | 8.29E-03 | 1 | P22557 | ALAS2 | More | | Pyridoxal-phosphate | hsa00410 | beta-Alanine metabolism | 4.50E-02 | 1 | Q6ZQY3 | GADL1 | More | | Pyridoxal-phosphate | hsa00471 | D-Glutamine and D-glutamate metabolism | 2.28E-02 | 1 | Q7Z3D6 | C14orf159 | More | | Pyridoxal-phosphate | hsa00500 | Starch and sucrose metabolism | 3.88E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Pyridoxal-phosphate | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 4.50E-02 | 1 | Q14442 | PIGH | More | | Pyridoxal-phosphate | hsa00565 | Ether lipid metabolism | 4.50E-02 | 1 | Q8N661 | TMEM86B | More | | Pyridoxal-phosphate | hsa00730 | Thiamine metabolism | 3.79E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Pyridoxal-phosphate | hsa00770 | Pantothenate and CoA biosynthesis | 2.28E-02 | 1 | Q6ZQY3 | GADL1 | More | | Pyridoxal-phosphate | hsa00860 | Porphyrin and chlorophyll metabolism | 3.28E-02 | 1 | P22557 | ALAS2 | More | | Pyridoxal-phosphate | hsa04062 | Chemokine signaling pathway | 1.81E-02 | 3 | P10145, P09769, Q13009 | IL8, FGR, TIAM1 | More | | Pyridoxal-phosphate | hsa04064 | NF-kappa B signaling pathway | 2.29E-03 | 11 | Q07817, P10415, O00463, P01375, Q04759, Q13077, P19784, Q16548, Q8WV28, P24522, P09341 | BCL2L1, BCL2, TRAF5, TNF, PRKCQ, TRAF1, CSNK2A2, BCL2A1, BLNK, GADD45A, CXCL1 | More | | Pyridoxal-phosphate | hsa04071 | Sphingolipid signaling pathway | 2.06E-02 | 7 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Pyridoxal-phosphate | hsa04080 | Neuroactive ligand-receptor interaction | 2.54E-02 | 7 | P08311, Q15722, Q9H228, P21462, P21730, Q16581, P35318 | CTSG, LTB4R, EDG8, FPR1, C5AR1, C3AR1, ADM | More | | Pyridoxal-phosphate | hsa04115 | p53 signaling pathway | 4.09E-02 | 1 | Q07817 | BCL2L1 | More | | Pyridoxal-phosphate | hsa04137 | Mitophagy - animal | 1.51E-03 | 2 | P19784, Q07817 | CSNK2A2, BCL2L1 | More | | Pyridoxal-phosphate | hsa04215 | Apoptosis - multiple species | 2.47E-02 | 1 | Q07817 | BCL2L1 | More | | Pyridoxal-phosphate | hsa04340 | Hedgehog signaling pathway | 1.43E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Pyridoxal-phosphate | hsa04520 | Adherens junction | 4.09E-02 | 1 | P19784 | CSNK2A2 | More | | Pyridoxal-phosphate | hsa04613 | Neutrophil extracellular trap formation | 1.37E-02 | 12 | O60603, P05164, P08246, Q9UM07, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Pyridoxal-phosphate | hsa04621 | NOD-like receptor signaling pathway | 2.64E-02 | 10 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, TNF, CXCL1, DEFA4 | More | | Pyridoxal-phosphate | hsa04657 | IL-17 signaling pathway | 1.28E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Pyridoxal-phosphate | hsa04658 | Th1 and Th2 cell differentiation | 3.21E-03 | 9 | Q04759, P20963, P09693, Q16539, Q14765, P42226, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, STAT6, GATA3, TBX21, HLA-DOB | More | | Pyridoxal-phosphate | hsa04659 | Th17 cell differentiation | 3.18E-02 | 8 | Q04759, Q16539, P42226, P13765, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, STAT6, HLA-DOB, TBX21, GATA3, CD3G, CD247 | More | | Pyridoxal-phosphate | hsa04660 | T cell receptor signaling pathway | 1.07E-02 | 9 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, MAPK14, GSK3B | More | | Pyridoxal-phosphate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.91E-02 | 2 | P19784, Q07817 | CSNK2A2, BCL2L1 | More | | Pyridoxal-phosphate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.89E-03 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Pyridoxal-phosphate | hsa05150 | Staphylococcus aureus infection | 4.37E-02 | 6 | P21730, P21462, O75015, P13765, Q16581, P12838 | C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, DEFA4 | More | | Pyridoxal-phosphate | hsa05162 | Measles | 5.54E-03 | 2 | P19784, Q07817 | CSNK2A2, BCL2L1 | More | | Pyridoxal-phosphate | hsa05169 | Epstein-Barr virus infection | 4.32E-02 | 11 | P13765, O00463, P16070, P10415, Q16539, P24522, Q8WV28, P01375, O60603, P09693, P20963 | HLA-DOB, TRAF5, CD44, BCL2, MAPK14, GADD45A, BLNK, TNF, TLR2, CD3G, CD247 | More | | Pyridoxal-phosphate | hsa05202 | Transcriptional misregulation in cancer | 8.07E-04 | 14 | Q15532, P14780, P27930, Q16548, Q13077, Q15652, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P24522 | SS18, MMP9, IL1R2, BCL2A1, TRAF1, JMJD1C, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, GADD45A | More | | Pyridoxal-phosphate | hsa05217 | Basal cell carcinoma | 1.43E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Pyridoxal-phosphate | hsa05220 | Chronic myeloid leukemia | 4.89E-02 | 1 | Q07817 | BCL2L1 | More | | Pyridoxal-phosphate | hsa05321 | Inflammatory bowel disease | 7.62E-04 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P42226, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, STAT6, GATA3 | More | | Pyridoxal-phosphate | hsa05323 | Rheumatoid arthritis | 4.28E-02 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | |